14,500+ years ago (End of the Pleistocene Era)
Volcanic ash Lahar embeds in topical depression, now seaside
Heiltsuk First Nation people began use as a healing clay for topical and internal treatments
Samples were transported to Massachusetts Institute of Technology
Dr. Ernst Hauser, Colloid Scientist - Massachusetts Institute of Technology
“It is concluded that the Kisameet Bay deposit is an aluminum silicate, which differs from all other known clay minerals not only in its composition but also in its properties. This product, therefore, deserves special attention not only from a geological and mineralogical point of view but also from a colloid chemical and very definitely from a medical point of view.”
1950’s - Rayvite
Reports of 25 or 50 tonnes mined and sold as curatives, cosmetics, and to Vancouver General Hospital by a Vancouver company, which operated for approximately 15 years.
1960’s - Pharmacology
Emergence of Pharma edges out local and natural curatives worldwide. Subsequently, the VGH Burn Unit stops using the mineral clay as an antibacterial.
2006 - Lawry Lund & Ross Wilson
Ross Wilson, former Chief of the Heiltsuk Tribal Council, informs Lawry Lund of the mineral clay deposit and its historic use by the Heiltsuk people as a healing clay. Lund, Doug Frankiw and Rowland Hanson incorporate Kisameet Glacial Clay Inc.
2010 - Period of due diligence leads to first sampling programs
2011 - Kisameet Glacial Clay Inc.
Kisameet Glacial Clay Inc. signs an Operating Agreement to control mineral claims.
2012 - Start of academic and commercial research
From 2012 to 2016 over $1.5 million was spent on research at five Faculties of Science.
2014 - Extraction of first bulk sample
Twelve tonnes of mineral clay is extracted and used for bulk sample batches for test drying, pulverizing and milling equipment.
2016 - mBio, American Society of Microbiology, publishes an article on Kisolite
On March 24, 2016 a white paper was issued from a group of research scientists entitled, “Kisameet Clay Isolated from the Central Coast of British Columbia, Canada, Demonstrates Broad-Spectrum Antimicrobial Activity”.
2017 - Revised and Amended Operating Agreement
Confirms production processes and terms for a powdered ingredient.
2017 - On April 12, 2017 a white paper was issued from a group of research scientists entitled, “Kisameet Clay Isolated from the Central Coast of British Columbia, Canada, Demonstrates Broad-Spectrum Antimicrobial Activity” receives global media coverage.
2018 - Incorporates Kisolite Corp.
In a Plan of Arrangement the Intellectual Property Rights (IP), Trademarks and Licenses are exclusively assigned in a share transaction agreement, for the purpose of Kisolite Corp conducting all sales, marketing and product development for the commercialization of Kisolite.
2018, Q3 - Full Production Startup
A 2,100 modern, high-ceiling commercial facility in Squamish, BC is staffed and operational for drying, pulverizing and milling of a finished product - Kisolite. Coastal extraction operations target 100-tonne inventory as supply through to Q2, 2019.